CXCR4 and breast carcinoma: Breast cancer cell adhesion and migration through a normal human umbilical vein endothelial cell (HUVEC) monolayer is significantly reduced by inhibiting CXCR4 or treating ECs with an SDF-1 neutralizing antibody.